Promoter Hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA Pathway in Cervical Cancer

Cancer Research

Volumn 64, Issue 9, 2004, Pages 2994-2997

  Narayan, Gopeshwar ^a   Arias Pulido, Hugo ^a   Nandula, Subhadra V ^b   Basso, Katia ^a   Sugirtharaj, Dorcas D ^a   Vargas, Hernan ^a   Mansukhani, Mahesh ^c   Villella, Jeannine ^a   Meyer, Larissa ^a   Schneider, Achim ^d   Gissmann, Lutz ^e   Dürst, Matthias ^d   Pothuri, Bhavana ^a   Murty, Vundavalli V V S ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c Instituto Nacional de Cancerología   (Colombia)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; DNA METHYLATION; FANCF GENE; GENE; GENETIC RISK; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ALKYLATING AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; DNA METHYLATION; DOWN-REGULATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; MITOMYCIN; PROMOTER REGIONS (GENETICS); RNA-BINDING PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 2342633174     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0245     Document Type: Article

References (20)

1. Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25.
2. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 2003;36:233-41.
3. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-56.
4. Wilkinson EJ, Morgan LS, Friedrich EG Jr. Association of Fanconi's anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases. J Reprod Med 1984;29:447-53.
5. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001;2:446-57.
6. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34.
7. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003;9:568-74.
8. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004;23:1000-4.
9. Narayan G, Arias-Pulido H, Koul S, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2003;2:24.
10. Califano A. SPLASH: structural pattern localization analysis by sequential histograms. Bioinformatics 2000;16:341-57.
11. Califano A, Stolovitzky G, Tu Y. Analysis of gene expression microarrays for phenotype classification. Proc Int Conf Intell Syst Mol Biol 2000;8:75-85.
12. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54:4481-7.
13. Pulido HA, Fakruddin MJ, Chatterjee A, et al. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 2000;60:6677-82.
14. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-8.
15. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
16. Seal S, Barfoot R, Jayatilake H, et al. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res 2003;63:8596-9.
17. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
18. Fahmer JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002;62:7213-8.
19. Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003;3:89-95.
20. Shimamura A, de Oca RM, Svenson JL, et al. A novel diagnostic screen for defects in the Fanconi anemia pathway Blood 2002;100:4649-54.